2022 annual financial data
Lisata Therapeutics 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -17.44%.
Operating income was -57,601,000 USD and net income was -54,225,000 USD.
Operating cash flow was -21,170,000 USD.
Get free Lisata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 121,372,000 USD
- Operating income
- -57,601,000 USD
- Net income
- -54,225,000 USD
- Operating cash flow
- -21,170,000 USD